MARKET

CAI

CAI

Caris Life Sciences, Inc.
NASDAQ
22.17
-0.14
-0.63%
After Hours: 22.60 +0.43 +1.94% 19:25 02/10 EST
OPEN
22.37
PREV CLOSE
22.31
HIGH
23.00
LOW
22.08
VOLUME
1.40M
TURNOVER
--
52 WEEK HIGH
42.50
52 WEEK LOW
21.18
MARKET CAP
6.26B
P/E (TTM)
-10.0077
1D
5D
1M
3M
1Y
5Y
1D
Caris Life Sciences Inc. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht
Reuters · 1d ago
Caris Life Sciences Inc. to report fourth quarter and full year 2025 financial results
Reuters · 1d ago
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26
PR Newswire · 1d ago
Weekly Report: what happened at CAI last week (0202-0206)?
Weekly Report · 1d ago
Caris Life Sciences, Inc.'s (NASDAQ:CAI) Shares May Have Run Too Fast Too Soon
Simply Wall St · 5d ago
Oversold Conditions For Caris Life Sciences (CAI)
NASDAQ · 6d ago
Weekly Report: what happened at CAI last week (0126-0130)?
Weekly Report · 02/02 09:51
Caris Life Sciences Identifies Key Resistance Mechanisms to Trastuzumab Deruxtecan in Metastatic Breast Cancer
Reuters · 01/28 13:31
More
About CAI
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Webull offers Caris Life Sciences, Inc. stock information, including NASDAQ: CAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAI stock methods without spending real money on the virtual paper trading platform.